Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Katzenstein

Showing results (91-100 of 162) with videos related to

Pageof 17
Sort By:
Annals of Internal Medicine|August 15, 1994
Didanosine resistance in HIV-infected patients switched from zidovudine to didanosine monotherapyM J Kozal, K Kroodsma, M A Winters, et al.
The Journal of Infectious Diseases|January 1, 2003
Prognostic value of baseline human immunodeficiency virus type 1 DNA measurement for disease progression in patients receiving nucleoside therapyCamlin Tierney, Janet L Lathey, Cindy Christopherson, et al.
AIDS Research and Human Retroviruses|February 15, 2001
Virologic and CD4 cell response to zidovudine or zidovudine and lamivudine following didanosine treatment of human immunodeficiency virus infectionD A Katzenstein, M D Hughes, M Albrecht, et al.
Journal of Acquired Immune Deficiency Syndromes|January 1, 1992
Plasma viremia in human immunodeficiency virus infection: relationship to stage of disease and antiviral treatmentD A Katzenstein, M Holodniy, D M Israelski, et al.
Human Immunology|October 24, 2002
Association of high HIV-1 RNA levels and homozygosity at HLA class II DRB1 in adults coinfected with Mycobacterium tuberculosis in Harare, ZimbabweLynn S Zijenah, Wendy E Hartogensis, David A Katzenstein, et al.
AIDS Research and Human Retroviruses|August 10, 2000
Virologic and CD4+ cell responses to new nucleoside regimens: switching to stavudine or adding lamivudine after prolonged zidovudine treatment of human immunodeficiency virus infection. ACTG 302 Study Team. AIDS Clinical Trials GroupD A Katzenstein, M Hughes, M Albrecht, et al.
Journal of Translational Medicine|August 16, 2006
Affordable flow cytometry for enumeration of absolute CD4+ T-lymphocytes to identify subtype C HIV-1 infected adults requiring antiretroviral therapy (ART) and monitoring response to ART in a resource-limited settingLynn S Zijenah, Gerard Kadzirange, Simon Madzime, et al.
AIDS (London, England)|January 6, 1999
Neuromuscular function in HIV infection: analysis of a placebo-controlled combination antiretroviral trial. AIDS Clinical Group 175/801 Study TeamD M Simpson, D A Katzenstein, M D Hughes, et al.
AIDS (London, England)|February 9, 2002
Severity of HIV-associated neuropathy is associated with plasma HIV-1 RNA levelsDavid M Simpson, Anna-Bettina Haidich, Giovanni Schifitto, et al.
The Central African Journal of Medicine|September 26, 2007
A pilot study to assess the immunologic and virologic efficacy of generic nevirapine, zidovudine and lamivudine in the treatment of HIV-1 infected women with pre-exposure to single dose nevirapine or short course zidovudine and their spouses in Chitungwiza, ZimbabweL S Zijenah, G Kadzirange, S Rusakaniko, et al.
Pageof 17

Showing results (91-100 of 162) with videos related to

Sort By:
Pageof 17
Annals of Internal Medicine|August 15, 1994
Didanosine resistance in HIV-infected patients switched from zidovudine to didanosine monotherapyM J Kozal, K Kroodsma, M A Winters, et al.
The Journal of Infectious Diseases|January 1, 2003
Prognostic value of baseline human immunodeficiency virus type 1 DNA measurement for disease progression in patients receiving nucleoside therapyCamlin Tierney, Janet L Lathey, Cindy Christopherson, et al.
AIDS Research and Human Retroviruses|February 15, 2001
Virologic and CD4 cell response to zidovudine or zidovudine and lamivudine following didanosine treatment of human immunodeficiency virus infectionD A Katzenstein, M D Hughes, M Albrecht, et al.
Journal of Acquired Immune Deficiency Syndromes|January 1, 1992
Plasma viremia in human immunodeficiency virus infection: relationship to stage of disease and antiviral treatmentD A Katzenstein, M Holodniy, D M Israelski, et al.
Human Immunology|October 24, 2002
Association of high HIV-1 RNA levels and homozygosity at HLA class II DRB1 in adults coinfected with Mycobacterium tuberculosis in Harare, ZimbabweLynn S Zijenah, Wendy E Hartogensis, David A Katzenstein, et al.
AIDS Research and Human Retroviruses|August 10, 2000
Virologic and CD4+ cell responses to new nucleoside regimens: switching to stavudine or adding lamivudine after prolonged zidovudine treatment of human immunodeficiency virus infection. ACTG 302 Study Team. AIDS Clinical Trials GroupD A Katzenstein, M Hughes, M Albrecht, et al.
Journal of Translational Medicine|August 16, 2006
Affordable flow cytometry for enumeration of absolute CD4+ T-lymphocytes to identify subtype C HIV-1 infected adults requiring antiretroviral therapy (ART) and monitoring response to ART in a resource-limited settingLynn S Zijenah, Gerard Kadzirange, Simon Madzime, et al.
AIDS (London, England)|January 6, 1999
Neuromuscular function in HIV infection: analysis of a placebo-controlled combination antiretroviral trial. AIDS Clinical Group 175/801 Study TeamD M Simpson, D A Katzenstein, M D Hughes, et al.
AIDS (London, England)|February 9, 2002
Severity of HIV-associated neuropathy is associated with plasma HIV-1 RNA levelsDavid M Simpson, Anna-Bettina Haidich, Giovanni Schifitto, et al.
The Central African Journal of Medicine|September 26, 2007
A pilot study to assess the immunologic and virologic efficacy of generic nevirapine, zidovudine and lamivudine in the treatment of HIV-1 infected women with pre-exposure to single dose nevirapine or short course zidovudine and their spouses in Chitungwiza, ZimbabweL S Zijenah, G Kadzirange, S Rusakaniko, et al.
Pageof 17